NDC 72162-2597-01 - GLYCOPYRROLATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2597
- Requested NDC
- 72162-2597-01
- Package NDCs from labels
- 72162-2597-1, 72162-2597-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-01-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYCOPYRROLATE - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-01-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2597-1 | GLYCOPYRROLATE | 100 in 1 BOTTLE | Tablet | 100 | 100 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2597-1 | EA - Each | 72162-2597 | 0c3eb861-de19-43eb-b928-619b53fedcf0 | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 8b4d1798-c0a7-4661-99cd-1e9a23c16386 | 2025-10-16 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Hikma Pharmaceuticals USA Inc. | 960d2dd0-008d-4ec1-ba2e-9388b28b23e2 | 2025-10-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 3f2b4281-55f3-43e3-e063-6294a90a56ba | 2025-09-18 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | ProPharma Distribution | 3edcc39d-0e29-4585-e063-6394a90ad512 | 2025-09-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 3edd6a26-dd0f-2411-e063-6394a90affa2 | 2025-09-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | FZ989GH94E |
| Glycopyrrolate | GLYCOPYRROLATE | Alembic Pharmaceuticals Inc. | 327f8a9e-7730-4f38-a7aa-fbddebddf173 | 2025-08-26 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Precision Dose, Inc. | e58f860b-e955-4d71-a128-93bd3812b08d | 2025-08-08 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYRX-PF | GLYCOPYRROLATE | Exela Pharma Sciences, LLC | 2189f3f5-39dc-4e85-b7c6-9515ded59686 | 2025-07-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | c277f1d8-2ee0-4111-adb6-38998f77dede | 2025-07-18 | Warnings | L11K75P92J |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | 81d59754-1b36-4f71-aec1-5335b003a96f | 2025-07-01 | Warnings | L11K75P92J |
| GLYCOPYRROLATE | GLYCOPYRROLATE | QUAGEN PHARMACEUTICALS LLC | a456eaea-4cd6-4344-8fc6-6f6a3ce0f2c6 | 2025-06-14 | Warnings, Adverse reactions | ANDA212696 70752-108 197739 197738 b1a27fc3-9dba-4a06-9033-349cace6a181 a456eaea-4cd6-4344-8fc6-6f6a3ce0f2c6 V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | American Health Packaging | 6404fc8e-d109-4950-9dca-c8a85ad90cf3 | 2025-05-18 | Warnings, Adverse reactions | 197738 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Leading Pharma, LLC | 498bce66-6072-4212-8413-ff9888c58f9c | 2025-04-25 | Warnings, Adverse reactions | 197739 197738 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Chartwell RX, LLC | 89090b34-470c-478c-be49-1d2bc48a28f8 | 2025-04-17 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Aurobindo Pharma Limited | 4b3f8b3e-6fa8-471b-8bee-3dac5e3ea1b8 | 2025-04-17 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | AvPAK | bd497783-e2d1-130c-e053-2995a90a7fb9 | 2025-03-04 | Warnings, Adverse reactions | 197738 V92SO9WP2I |
| Walgreens Soothing Eye Relief Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Walgreens Co. | 29b7387b-ad65-3a11-e063-6394a90a6a15 | 2025-02-14 | Warnings | FZ989GH94E |
| Glycopyrrolate | GLYCOPYRROLATE | Caplin Steriles Limited | 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | 2025-01-25 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9a3a142c-daaf-79af-e053-2995a90a1c51 | 2025-01-08 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.